MIGRAINE RESEARCH
FOR CHILDREN AND TEENS 6 TO 17 YEARS OLD

Watching a child have to deal with migraines can be frustrating when nothing seems to help them.

Not just adults get migraine, children do too. Researchers found that up to 10% of school-age children have headache attacks that cause pain and leave them unable to function properly. Children and teens who suffer from migraine may end up missing school, not participating in activities they love, and feeling isolated because they are unable to spend time with friends.

Access Clinical Trials in Nashville is running a research study to evaluate the safety and efficacy of a dissolving tablet called rimegepant in children and teens 6 to 17 years old with moderate to severe migraine. Rimegepant is approved by the US Food and Drug Administration (FDA) for the acute treatment of migraine in adults. If you would like to know more about this study and see if it might be right for your child or teen, please complete the form to get in touch with the study coordinator.

We Are Looking for Children/Teens Who:

Are between the ages of 6 and 17
Have a history of migraine attacks for 6 months or longer
Have had 1 to 8 migraine attacks per month during the past 2 months
Have a parent, caregiver, or legal guardian to give informed consent and to help them throughout the study

Participants Will Receive:

Study-related medical care at no cost
Investigational medication from a local physician at no cost
Compensation for time and travel

Find out if your child or teen qualifies today.

To contact the study coordinator, please enter the following information:

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid mobile number.

Please enter valid zip code.

Your privacy is important to us. By clicking "Submit" you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.